OP112 Evaluation Of A Self-Administered Smart Phone-Based Application As A Wellness Measure In A Clinical Trial Of Zanubrutinib von Crescenzo, Rocco, Idoine, Adam, By, Kunthel, Yang, Keri

Volltext

FDA Approval Summary: Glasdegib for Newly Diagnosed Acute Myeloid Leukemia von Norsworthy, Kelly J, By, Kunthel, Subramaniam, Sriram, Zhuang, Luning, Del Valle, Pedro L, Przepiorka, Donna, Shen, Yuan-Li, Sheth, Christopher M, Liu, Chao, Leong, Ruby, Goldberg, Kirsten B, Farrell, Ann T, Pazdur, Richard

Volltext

Genomic landscape of patients in a phase II study of zanubrutinib in ibrutinib- and/or acalabrutinib-intolerant patients with B-cell malignancies von Xu, Linlin, Shadman, Mazyar, Flinn, Ian W, Levy, Moshe Y, Porter, Ryan, Burke, John M, Zafar, Syed F, Cultrera, Jennifer L, Misleh, Jamal, Kingsley, Edwin C, Yimer, Habte A, Freeman, Benjamin, Chaudhry, Arvind, Tumula, Praveen K, Gandhi, Mitul D, Crescenzo, Rocco, By, Kunthel, Cohen, Aileen, Chen, Dih-Yih, Idoine, Adam, Manda, Sudhir, Sharman, Jeff P, Ramakrishnan, Vanitha

Volltext

Study Methods, Recruitment, Sociodemographic Findings, and Demographic Representativeness in the OPPERA Study von Slade, Gary D, Bair, Eric, By, Kunthel, Mulkey, Flora, Baraian, Cristina, Rothwell, Rebecca, Reynolds, Maria, Miller, Vanessa, Gonzalez, Yoly, Gordon, Sharon, Ribeiro-Dasilva, Margarete, Lim, Pei Feng, Greenspan, Joel D, Dubner, Ron, Fillingim, Roger B, Diatchenko, Luda, Maixner, William, Dampier, Dawn, Knott, Charles, Ohrbach, Richard

Volltext

Zanubrutinib, Alone and in Combination With Tislelizumab, for the Treatment of Richter Transformation of Chronic Lymphocytic Leukemia von Tam, Constantine, Munoz, Javier, Cull, Gavin, Opat, Stephen, Allewelt, Heather, Zhang, Xiaoping, Stern, Jennifer C., Hilger, James, By, Kunthel, Cohen, Aileen, Tedeschi, Alessandra

Volltext

Important statistical considerations in the evaluation of post‐market studies to assess whether opioids with abuse‐deterrent properties result in reduced abuse in the community von By, Kunthel, McAninch, Jana K., Keeton, Stephine L., Secora, Alex, Kornegay, Cynthia J., Hwang, Catherine S., Ly, Thomas, Levenson, Mark S.

Volltext

P633: UPDATED SAFETY AND EFFICACY RESULTS OF ZANUBRUTINIB IN PATIENTS WITH B‐CELL MALIGNANCIES WHO ARE INTOLERANT OF IBRUTINIB AND/OR ACALABRUTINIB von Shadman, Mazyar, Y. Levy, Moshe, Porter, Ryan, M. Burke, John, L. Cultrera, Jennifer, Misleh, Jamal, Sharman, Jeff, F. Zafar, Syed, By, Kunthel, Cohen, Aileen, Crescenzo, Rocco, Idoine, Adam, W. Flinn, Ian

Volltext

Zanubrutinib in Acalabrutinib-Intolerant Patients (Pts) with B-Cell Malignancies von Shadman, Mazyar, Flinn, Ian W., Kingsley, Edwin C., Freeman, Benjamin B., Levy, Moshe, Farber, Charles M., D'Olimpio, James, Cultrera, Jennifer L., Zhang, Ben, Crescenzo, Rocco J., Idoine, Adam, Zhang, Xiaoping, By, Kunthel, Sharman, Jeff P.

Volltext

Analysis of early mortality in randomized clinical trials evaluating anti-PD-1/PD-L1 antibodies: A systematic analysis by the United States Food and Drug Administration (FDA) von Mulkey, Flora, By, Kunthel, Theoret, Marc Robert, Maher, Virginia Ellen, Pazdur, Richard, Sridhara, Rajeshwari

Volltext

Zanubrutinib in Acalabrutinib-Intolerant Patients (Pts) with B-Cell Malignancies von Shadman, Mazyar, Flinn, Ian W., Kingsley, Edwin C., Freeman, Benjamin, Levy, Moshe Yair, Holmes, Houston, Farber, Charles M., Chaudhry, Arvind, Crescenzo, Rocco, Idoine, Adam, Zhang, Xiaoping, Cohen, Aileen, By, Kunthel, Huang, Jane, Sharman, Jeff P.

Volltext

First Results from a Phase 1, First-in-Human Study of the Bruton's Tyrosine Kinase (BTK) Degrader Bgb-16673 in Patients (Pts) with Relapsed or Refractory (R/R) B-Cell Malignancies... von Seymour, John F., Cheah, Chan Yoon, Parrondo, Ricardo, Thompson, Meghan C., Stevens, Don A., Lasica, Masa, Wang, Michael L., Kumar, Abhijeet, Trotman, Judith, Alwan, Maan, Ding, Wei, By, Kunthel, Tariq, Bilal, Chen, Xiangmei, Fabre, Shannon, Paik, Jason, Agarwal, Amit, Tam, Constantine S.

Volltext

Genomic Landscape of Ibrutinib- and/or Acalabrutinib-intolerant Patients with B-cell Malignancies Treated with Zanubrutinib in a Phase 2 Study von Xu, Linlin, Shadman, Mazyar, Flinn, Ian W., Levy, Moshe, Porter, Ryan, Burke, John M., Zafar, Syed F., Cultrera, Jennifer L., Misleh, Jamal, Kingsley, Edwin C., Yimer, Habte A., Freeman, Benjamin B., Chaudhry, Arvind, Tumula, Praveen K., Gandhi, Mitul, Crescenzo, Rocco J., By, Kunthel, Cohen, Aileen Cleary, Idoine, Adam, Manda, Sudhir, Sharman, Jeff P.

Volltext

FDA Analysis of Outcomes in Older Adults with Relapsed or Refractory Multiple Myeloma von Kanapuru, Bindu, Jin, Susan, By, Kunthel, Shen, Yuan Li, Carioti, Theresa, Gormley, Nicole, Farrell, Ann T., Pazdur, Richard

Volltext

Role of Allostatic Load in Sociodemographic Patterns of Pain Prevalence in the U.S. Population von Slade, Gary D, Sanders, Anne E, By, Kunthel

Volltext

Zanubrutinib in patients with previously treated B-cell malignancies intolerant of previous Bruton tyrosine kinase inhibitors in the USA: a phase 2, open-label, single-arm study von Shadman, Mazyar, Flinn, Ian W, Levy, Moshe Y, Porter, Ryan F, Burke, John M, Zafar, Syed F, Misleh, Jamal, Kingsley, Edwin C, Yimer, Habte A, Freeman, Benjamin, Rao, Subramanya S, Chaudhry, Arvind, Tumula, Praveen K, Gandhi, Mitul D, Manda, Sudhir, Chen, Dih-Yih, By, Kunthel, Xu, Linlin, Liu, Ye, Crescenzo, Rocco, Idoine, Adam, Zhang, Xiaoping, Cohen, Aileen, Huang, Jane, Sharman, Jeff P

Volltext

FDA Analysis of Survival Outcomes in Older Adults with Relapsed-Refractory Multiple Myeloma (RRMM) Treated with Novel Drug Regimens von Kanapuru, Bindu, Jin, Susan, By, Kunthel, Carioti, Theresa, Shen, Yuan-Li, Sridhara, Rajeshwari, Gormley, Nicole J, Farrell, Ann T., Pazdur, Richard

Volltext

Phase 2 Study of Zanubrutinib in BTK Inhibitor-Intolerant Patients (Pts) with Relapsed/Refractory B-Cell Malignancies von Shadman, Mazyar, Flinn, Ian W., Levy, Moshe Y., Porter, Ryan, Burke, John M., Cultrera, Jennifer L., Misleh, Jamal, Zafar, Syed F., Freeman, Benjamin, Rao, Subramanya S., Yimer, Habte, Chaudhry, Arvind, Gandhi, Mitul D., Guthrie, Troy H., Kingsley, Edwin, Tumula, Praveen K., Manda, Sudhir, Chen, Dih-Yih, Cohen, Aileen, By, Kunthel, Xu, Linlin, Liu, Ye, Sharman, Jeff P.

Volltext

Evaluation of the correlation between antibiotic use and survival in patients with recurrent or metastatic head and neck squamous cell carcinoma (R/M HNSCC) treated with immune che... von Vellanki, Paz J., Marur, Shanthi, Bandaru, Pradeep, Mishra-Kalyani, Pallavi Shruti, By, Kunthel, Girvin, Andrew, Chatterjee, Somak, Singh, Harpreet, Keegan, Patricia, Larkins, Erin A., Cross, Frank, Pazdur, Richard, Theoret, Marc R.

Volltext

Zanubrutinib for the treatment of relapsed/refractory hairy cell leukemia von Tam, Constantine S., Trotman, Judith, Opat, Stephen, Stern, Jennifer C., Allewelt, Heather, By, Kunthel, Novotny, William, Huang, Jane, Tedeschi, Alessandra

Volltext

Abstract 2303: Entacapone and prostate cancer in patients with Parkinson’s disease: A large Veterans Health Administration study von Major, Jacqueline M., Cunningham, Francesca, Dong, Diane, By, Kunthel, Hur, Kwan, Shih, David C., Pinheiro, Simone P., Podskalny, Gerald D., Graham, David J.

Volltext